Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1279.6000 -16.90 (-1.30%)
NSE Mar 16, 2026 15:31 PM
Volume: 1.4M
 

1279.60
-1.30%
Geojit BNP Paribas
with multiple regulatory milestones lined up in the coming quarters. Execution of the pipeline delivery and expansion initiatives is expected to support long-term value creation. Therefore, we maintain our rating on the stock at BUY, with rolledforward target price of Rs. 1,348, based on 17.5x FY27x Adj. EPS....
Aurobindo Pharma Ltd. has an average target of 1332.89 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended